Cargando…

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients

Purpose: Lymphocytes are central players in systemic anti-tumor immune responses. In this study, we aimed to identify the relationship between absolute lymphocyte count (ALC) nadir during definitive radiotherapy (RT) and survival outcomes in patients with esophageal squamous cell carcinoma (ESCC), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin, Zhao, Zongxing, Wang, Peiliang, Geng, Xiaotao, Zhu, Liqiong, Li, Minghuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324641/ https://www.ncbi.nlm.nih.gov/pubmed/32656085 http://dx.doi.org/10.3389/fonc.2020.00997

Ejemplares similares

Corrigendum: Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2021)

The Prognostic Significance of Metastatic Nodal Size in Non-surgical Patients With Esophageal Squamous Cell Carcinoma
por: Zhao, Zongxing, et al.
Publicado: (2020)

Lymph node metastasis is not associated with survival in patients with clinical stage T4 esophageal squamous cell carcinoma undergoing definitive radiotherapy or chemoradiotherapy
por: Zhu, Liqiong, et al.
Publicado: (2022)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma
por: Zhao, Zongxing, et al.
Publicado: (2019)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Abdominal lymph node metastasis in non-surgical esophageal squamous cell carcinoma: prognostic significance and a novel staging strategy
por: Zhao, Zongxing, et al.
Publicado: (2023)

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance
por: Tian, Xiufang, et al.
Publicado: (2023)

Prognostic Significance of Baseline Neutrophil Count and Lactate Dehydrogenase Level in Patients With Esophageal Squamous Cell Cancer Treated With Radiotherapy
por: Luo, He-San, et al.
Publicado: (2020)

Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma
por: Li, Kaixin, et al.
Publicado: (2022)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
por: Liu, Jihui, et al.
Publicado: (2023)

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients
por: Liu, Ao, et al.
Publicado: (2021)

Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma
por: Sun, Lu, et al.
Publicado: (2023)

Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis
por: Hao, Jiatao, et al.
Publicado: (2020)

Subcutaneous soft tissue metastases from esophageal squamous cell carcinoma with neuroendocrine differentiation: Case report and literature review
por: Geng, Xiaotao, et al.
Publicado: (2022)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma
por: Tamura, Akihiro, et al.
Publicado: (2020)

Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
por: Cui, Yongbin, et al.
Publicado: (2022)

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
por: Sun, Xin, et al.
Publicado: (2020)

Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
por: Qin, Qin, et al.
Publicado: (2020)

Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
por: Ji, Wenbing, et al.
Publicado: (2021)

Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting
por: Li, Li-Qing, et al.
Publicado: (2022)

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
por: Chan-Jun, Zhen, et al.
Publicado: (2023)

Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX
por: Xu, Pengqin, et al.
Publicado: (2021)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients
por: Gui, Zhongxuan, et al.
Publicado: (2022)

Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
por: Wang, Yichun, et al.
Publicado: (2021)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
por: Tang, Peng, et al.
Publicado: (2021)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
por: Wu, Rong, et al.
Publicado: (2020)

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
por: Li, Chen, et al.
Publicado: (2021)

Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy
por: Li, Zhenjiang, et al.
Publicado: (2019)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
por: Guo, SuPing, et al.
Publicado: (2021)

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
por: Chow, Ronald, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3mr4hm2h31p24q8opphhkr49u